Avery Ince, VP, Medical Affairs - CVM Franchise, Janssen Shares his Views on New Data from P-III VOYAGER PAD Trial
Shots: Avery spoke about the study design and the new data obtained from the P-III...
Shots: Avery spoke about the study design and the new data obtained from the P-III...
Shots: Anas spoke about revenue cycle management in the healthcare sector and the...
Shots: Eric shared the results from the first immunological results of its PDC-LUN...
Shots: Monica spoke about the new data from its multiple sclerosis therapies port...
Shots: Gregory initially spoke about the Attralus licensing agreement with Ossiani...
Shots: David first talked about Clarivate’s Highly Cited Researchers 2022 l...
Incisive News in 3 Shots.